Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.
about
Hereditary alpha-1-antitrypsin deficiency and its clinical consequencesGenes and chronic obstructive pulmonary diseaseAlpha1-antitrypsin deficiency. 2: genetic aspects of alpha(1)-antitrypsin deficiency: phenotypes and genetic modifiers of emphysema riskalpha1-Antitrypsin deficiency . 6: new and emerging treatments for alpha1-antitrypsin deficiencyAlpha-1 antitrypsin deficiency is not a rare disease but a disease that is rarely diagnosedAlpha-1 antitrypsin deficiency targeted testing and augmentation therapy: a Canadian Thoracic Society clinical practice guidelinePrevalence of genetic polymorphisms in the promoter region of the alpha-1 antitrypsin (SERPINA1) gene in chronic liver disease: a case control studyAlpha 1 antitrypsin deficiency in infants with neonatal cholestasisUbiquitin ligase SYVN1/HRD1 facilitates degradation of the SERPINA1 Z variant/α-1-antitrypsin Z variant via SQSTM1/p62-dependent selective autophagy.Polymorphism of SERPINE2 gene is associated with pulmonary emphysema in consecutive autopsy casesAlpha-1 antitrypsin Pi*SZ genotype: estimated prevalence and number of SZ subjects worldwide.Should patients with abnormal liver function tests in primary care be tested for chronic viral hepatitis: cost minimisation analysis based on a comprehensively tested cohort.A genome-wide RNAi screen identifies potential drug targets in a C. elegans model of α1-antitrypsin deficiency.α₁-Antitrypsin protease inhibitor MZ heterozygosity is associated with airflow obstruction in two large cohorts.Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency.α1 Antitrypsin deficiency: current best practice in testing and augmentation therapy.Blocking formation of large protein aggregates by small peptides.Spontaneous hepatic repopulation in transgenic mice expressing mutant human α1-antitrypsin by wild-type donor hepatocytesIs PiSS Alpha-1 Antitrypsin Deficiency Associated with Disease?Alpha-1 proteinase inhibitors for the treatment of alpha-1 antitrypsin deficiency: safety, tolerability, and patient outcomes.Racial differences in CT phenotypes in COPD.Prevalence of α-1-antitrypsin gene mutations in Saudi Arabia.Mixture-based combinatorial libraries from small individual peptide libraries: a case study on α1-antitrypsin deficiency.Role of elastases in the pathogenesis of chronic obstructive pulmonary disease: implications for treatmentWhy has it been so difficult to prove the efficacy of alpha-1-antitrypsin replacement therapy? Insights from the study of disease pathogenesisIdentification of compound heterozygous mutation in a Korean patient with alpha 1-antitrypsin deficiency.Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis.How Can We Improve the Detection of Alpha1-Antitrypsin Deficiency?Rapid and inexpensive detection of alpha1-antitrypsin deficiency-related alleles S and Z by a real-time polymerase chain reaction suitable for a large-scale population-based screeningHealth implications of alpha1-antitrypsin deficiency in Sub-Sahara African countries and their emigrants in Europe and the New World.Alpha-1-antitrypsin deficiency: optimal therapeutic regimen based on population pharmacokinetics.Aralast: a new alpha1-protease inhibitor for treatment of alpha-antitrypsin deficiency.Alpha-1-antitrypsin deficiency in Serbian adults with lung diseases.The selective advantage of alpha1-antitrypsin deficiency.Philanthropy and Advocacy-Led Development of Gene Therapies and Drugs for Alpha-1 Antitrypsin Deficiency.Alpha-1 Antitrypsin Deficiency PI*Z and PI*S Gene Frequency Distribution Using on Maps of the World by an Inverse Distance Weighting (IDW) Multivariate Interpolation Method.Update on research, diagnosis and management of alphal-antitrypsin deficiency.On the synthesis and interpretation of consistent but weak gene-disease associations in the era of genome-wide association studies.Circulating alpha1-antitrypsin in the general population: determinants and association with lung function.Chronic hepatitis in West and East.
P2860
Q21202920-F7FC0BB9-8F37-417C-BAAF-E0418B8D9217Q24630805-99EE9FA0-D44E-4365-B31B-BFC16743F001Q24678705-C3377F10-9132-4986-AC84-2F24DA3AD687Q24678727-7E672113-6A56-4F32-8965-31FB597BE582Q24816929-60F6AF8C-9270-4150-81A8-C6F41252B682Q28385458-9DC1138D-409B-4FA9-B84E-7C458173FE91Q33532800-02DCD048-92AD-4A88-BB2E-6D016E36C47BQ33552040-A457DC71-82C9-46FC-BDFC-DEF1D79C1557Q33553536-E3ABC29A-5A13-4E36-BAAD-1856FCFE0F0BQ33743565-D8C43A2F-3096-4230-BCD2-6F1F986997E0Q33806741-15CC9B1C-A020-47E0-A53B-805074FF1E8DQ33836312-6044485C-34B7-4F2F-8B54-80BE595E6D60Q34155401-504C774F-8E3F-403B-9D78-58251318F513Q34275338-05135C07-182D-458E-8311-0C5FB17EF2DBQ34294602-3F9BEF15-4692-4583-A755-C8E6C5A23851Q34428735-E1B8CEE4-8760-4E6C-9659-3A864E7C5126Q34661105-8BAEF087-78F2-42B5-933E-74BB22E7CA65Q34876052-244FF954-9384-4E04-9C72-E734CCD95BDBQ34997267-B54AB82F-28A2-4FF9-9F31-6695B32718F6Q35063726-E25E16DE-642D-4FE0-9836-64D271BF1F05Q35064411-2C7F2E2F-6575-4268-B55C-6236B20DF9DBQ35098361-0CE0743C-9802-4F53-9813-291B87513B72Q35170932-7CC0FF90-D868-4943-B296-C1F9AD433632Q35179153-D4F4D49E-5ECB-4E65-8E6B-23CC2592489CQ35233352-65FC0A7B-6D5B-4269-BC29-99EF881B4601Q35300376-0BF04621-CE4B-4240-A35B-B77D92E1A098Q35536217-E3508F5D-8E44-41C5-B424-57750E217D1BQ35745026-6BB7CDDD-0AE4-4884-912A-8AB4CC86CFB2Q35789532-0664C168-AC44-4608-83CD-8FE3DEB9F193Q36073709-D09FBE67-E80D-457F-8E7A-99E4F504A0B9Q36225322-0611FFA4-F9EB-4030-A204-2619D7DD4CBFQ36284086-F1A7B836-5F90-40EB-825B-F44B34454869Q36353172-80F4EDF2-8524-4BAA-BBE5-6CC2633C0149Q36378692-039A80CB-2AFD-43D5-B9CC-1F664C2CBC3FQ36406846-73951064-83A9-4C9D-851B-EF798838712FQ36407173-09B40AAA-9091-47C6-A976-5B7BA8D477D9Q36669495-35287503-B9C0-4DC2-8A64-712D0CE6C173Q36689595-91448968-39AB-4BC9-A2F8-FD889ABC3217Q36700389-0B4C84A6-B7CB-4998-B829-E28654804F6FQ36935242-244508F5-51E2-44B1-96B5-FE7D9A495F9C
P2860
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.
description
2002 nî lūn-bûn
@nan
2002 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@ast
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@en
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@nl
type
label
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@ast
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@en
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@nl
prefLabel
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@ast
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@en
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@nl
P356
P1433
P1476
Worldwide racial and ethnic di ...... genetic epidemiologic surveys.
@en
P2093
Frederick J de Serres
P304
P356
10.1378/CHEST.122.5.1818
P407
P577
2002-11-01T00:00:00Z